Logo

Harvard Bioscience, Inc.

HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tis… read more

Healthcare

Medical Instruments & Supplies

22 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.49

Price

-3.51%

-$0.01

Market Cap

$21.687m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$91.397m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$58.051m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.32

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$14.835m

$79.801m

Assets

$64.966m

Liabilities

$44.607m

Debt
Debt to Assets

55.9%

-1.1x

Debt to EBITDA
Free Cash Flow

$586k

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases